Who invested in Evariant?
Evariant's investors include Lightspeed Venture Partners, Salesforce Ventures, Health Enterprise Partners, Goldman Sachs and Dignity Health.
United States · Series C startup
5 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$70Mraised across 5 rounds since 2011, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $42M sold, first sale Nov 2015
From a historical funding recordSEC filing: $17M sold, first sale May 2014
No investor was named in the report.
From a historical funding recordSEC filing: $1.5M sold, first sale Feb 2014
No investor was named in the report.
Reported by masshightech.comSEC filing: $2.6M sold, first sale May 2012
Reported by finsmes.comSEC filing: $5.3M sold, first sale Nov 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Evariant's investors include Lightspeed Venture Partners, Salesforce Ventures, Health Enterprise Partners, Goldman Sachs and Dignity Health.
Evariant has raised $70M across 5 rounds since 2011.
Evariant's most recent round was a Series C of $42M in Nov 2015.
Its most recent round, $42M in Nov 2015, is also its largest on record.
Evariant's first round on record, in Nov 2011, was backed by Health Enterprise Partners.
Evariant's latest named round is a Series C, in Nov 2015.
Evariant is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.